{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:00:24Z","timestamp":1791288024681,"version":"4.3.0"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>Despite national concerns over high rates of antipsychotic medication use among youth in foster care, concomitant antipsychotic use has not been examined. In this study, concomitant antipsychotic use among Medicaid-enrolled youth in foster care was compared with disabled or low-income Medicaid-enrolled youth.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS AND METHODS:<\/jats:title><jats:p>The sample included 16 969 youths younger than 20 years who were continuously enrolled in a Mid-Atlantic state Medicaid program and had \u22651 claim with a psychiatric diagnosis and \u22651 antipsychotic claim in 2003. Antipsychotic treatment was characterized by days of any use and concomitant use with \u22652 overlapping antipsychotics for &amp;gt;30 days. Medicaid program categories were foster care, disabled (Supplemental Security Income), and Temporary Assistance for Needy Families (TANF). Multicategory involvement for youths in foster care was classified as foster care\/Supplemental Security Income, foster care\/TANF, and foster care\/adoption. We used multivariate analyses, adjusting for demographics, psychiatric comorbidities, and other psychotropic use, to assess associations between Medicaid program category and concomitant antipsychotic use.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Average antipsychotic use ranged from 222 \u00b1 110 days in foster care to only 135 \u00b1 101 days in TANF (P &amp;lt; .001). Concomitant use for \u2265180 days was 19% in foster care only and 24% in foster care\/adoption compared with &amp;lt;15% in the other categories. Conduct disorder and antidepressant or mood-stabilizer use was associated with a higher likelihood of concomitant antipsychotic use (P &amp;lt; .0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Additional study is needed to assess the clinical rationale, safety, and outcomes of concomitant antipsychotic use and to inform statewide policies for monitoring and oversight of antipsychotic use among youths in the foster care system.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2010-2970","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T05:18:41Z","timestamp":1321939121000},"page":"e1459-e1466","source":"Crossref","is-referenced-by-count":92,"title":["Antipsychotic Treatment Among Youth in Foster Care"],"prefix":"10.1542","volume":"128","author":[{"given":"Susan","family":"dosReis","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesel","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Riddle","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Noll","sequence":"additional","affiliation":[{"name":"Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Rothbard","sequence":"additional","affiliation":[{"name":"Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"issue":"7","key":"2021120900385035200_B1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2105\/AJPH.91.7.1094","article-title":"Mental health services for youths in foster care and disabled youths","volume":"91","author":"dosReis","year":"2001","journal-title":"Am J Public Health"},{"issue":"1","key":"2021120900385035200_B2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/cap.2005.15.97","article-title":"Psychotropic medication use in a national probability sample of children in the child welfare system","volume":"15","author":"Raghavan","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"2021120900385035200_B3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/cap.1999.9.135","article-title":"Psychotropic medication treatment patterns among school-aged children in foster care","volume":"9","author":"Zima","year":"1999","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"2021120900385035200_B4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1176\/appi.ps.56.2.157","article-title":"Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths","volume":"56","author":"Zito","year":"2005","journal-title":"Psychiatr Serv"},{"issue":"6","key":"2021120900385035200_B5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1176\/appi.ps.55.6.706","article-title":"Use of psychotropic medications by youths in therapeutic foster care and group homes","volume":"55","author":"Breland-Noble","year":"2004","journal-title":"Psychiatr Serv"},{"issue":"1","key":"2021120900385035200_B6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-0212","article-title":"Psychotropic medication patterns among youth in foster care","volume":"121","author":"Zito","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"2021120900385035200_B7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-3713","article-title":"State variation in psychotropic medication use by foster care children with autism spectrum disorder","volume":"124","author":"Rubin","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"2021120900385035200_B8","first-page":"13","article-title":"Trends in antipsychotic drug use by very young, privately insured children","volume":"49","author":"Olfson","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"2021120900385035200_B9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2021120900385035200_B10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ambp.2005.11.002","article-title":"Trends in prescribing of antipsychotic medications for US children","volume":"6","author":"Cooper","year":"2006","journal-title":"Ambul Pediatr"},{"issue":"3","key":"2021120900385035200_B11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/104454602760386905","article-title":"Trends in antipsychotic use in a Texas Medicaid population of children and adolescents, 1996\u20132000","volume":"12","author":"Patel","year":"2002","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"2021120900385035200_B12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/ps.2008.59.5.507","article-title":"Who are the new users of antipsychotic medications?","volume":"59","author":"Domino","year":"2008","journal-title":"Psychiatr Serv"},{"issue":"10","key":"2021120900385035200_B13","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1176\/ps.2008.59.10.1162","article-title":"Changing trends in pediatric antipsychotic use in Florida's Medicaid program","volume":"59","author":"Constantine","year":"2008","journal-title":"Psychiatr Serv"},{"issue":"5","key":"2021120900385035200_B14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ps.2008.59.5.554","article-title":"Use of antipsychotic drugs among Dutch youths between 1997 and 2005","volume":"59","author":"Kalverdijk","year":"2008","journal-title":"Psychiatr Serv"},{"issue":"3","key":"2021120900385035200_B15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/ebmh.12.3.93","article-title":"Multiple antipsychotic use associated with metabolic and cardiovascular adverse events in children and adolescents","volume":"12","author":"Correll","year":"2009","journal-title":"Evid Based Ment Health"},{"issue":"5","key":"2021120900385035200_B16","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"2021120900385035200_B17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hup.700","article-title":"Antipsychotic drug use: McLean Hospital, 2002","volume":"20","author":"Centorrino","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"10","key":"2021120900385035200_B18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4088\/JCP.v65n1013","article-title":"Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998\u20132000","volume":"65","author":"Ganguly","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"2021120900385035200_B19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1176\/ps.2007.58.7.1007","article-title":"Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999\u20132004","volume":"58","author":"Gilmer","year":"2007","journal-title":"Psychiatr Serv"},{"issue":"1","key":"2021120900385035200_B20","first-page":"69","article-title":"Accuracy of diagnoses of schizophrenia in Medicaid claims","volume":"43","author":"Lurie","year":"1992","journal-title":"Hosp Community Psychiatry"},{"issue":"3","key":"2021120900385035200_B21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1021308007343","article-title":"Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery","volume":"27","author":"Walkup","year":"2000","journal-title":"Adm Policy Ment Health"},{"key":"2021120900385035200_B22","volume-title":"Medicaid as a Source for Postmarketing Surveillance Information, Final Report","author":"Lessler","year":"1984"},{"issue":"3","key":"2021120900385035200_B23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1367\/A04-120R.1","article-title":"A sampling bias in identifying children in foster care using Medicaid data","volume":"5","author":"Rubin","year":"2005","journal-title":"Ambul Pediatr"},{"issue":"4","key":"2021120900385035200_B24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/oxfordjournals.schbul.a006968","article-title":"Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia","volume":"28","author":"dosReis","year":"2002","journal-title":"Schizophr Bull"},{"issue":"6 pt 2","key":"2021120900385035200_B25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1542\/peds.89.6.1238","article-title":"Mental health service utilization by children in foster care in California","volume":"89","author":"Halfon","year":"1992","journal-title":"Pediatrics"},{"issue":"1","key":"2021120900385035200_B26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.schbul.a006920","article-title":"Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles","volume":"28","author":"Covell","year":"2002","journal-title":"Schizophr Bull"},{"issue":"10","key":"2021120900385035200_B27","first-page":"571","article-title":"When is antipsychotic polypharmacy supported by research evidence? Implications for QI","volume":"34","author":"Goren","year":"2008","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"8","key":"2021120900385035200_B28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/01.chi.0000127590.95585.65","article-title":"Mental health need and access to mental health services by youths involved with child welfare: a national survey","volume":"43","author":"Burns","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"2021120900385035200_B29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2105\/AJPH.2008.151472","article-title":"A preliminary analysis of the receipt of mental health services consistent with national standards among children in the child welfare system","volume":"100","author":"Raghavan","year":"2010","journal-title":"Am J Public Health"},{"issue":"7","key":"2021120900385035200_B30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"16","key":"2021120900385035200_B31","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"28","author":"Correll","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"2021120900385035200_B32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/0269881105056543","article-title":"Metabolic side effects of atypical antipsychotics in children: a literature review","volume":"19","author":"Fedorowicz","year":"2005","journal-title":"J Psychopharmacol"},{"issue":"3","key":"2021120900385035200_B33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"15","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"2021120900385035200_B34","first-page":"175","article-title":"Psychotropic medication management for youth in state care: consent, oversight, and policy considerations","volume":"86","author":"Naylor","year":"2007","journal-title":"Child Welfare"},{"issue":"11","key":"2021120900385035200_B35","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2105\/AJPH.89.11.1732","article-title":"Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders","volume":"89","author":"Zima","year":"1999","journal-title":"Am J Public Health"},{"issue":"12","key":"2021120900385035200_B36","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1176\/ps.2009.60.12.1595","article-title":"Identifying clinically questionable psychotropic prescribing practices for Medicaid recipients in New York state","volume":"60","author":"Essock","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"1","key":"2021120900385035200_B37","first-page":"71","article-title":"The use of psychotropic medication for children in foster care","volume":"88","author":"Crismon","year":"2009","journal-title":"Child Welfare"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/128\/6\/e1459\/845247\/zpe012110e1459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/128\/6\/e1459\/845247\/zpe012110e1459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T15:32:15Z","timestamp":1639755135000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/128\/6\/e1459\/31079\/Antipsychotic-Treatment-Among-Youth-in-Foster-Care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,1]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,12,1]]},"published-print":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-2970","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,1]]}}}